BIOV Stock Chart & Stats
CHF29.90
CHF0.68(1.92%)
At close: 4:00 PM EST
CHF29.90
CHF0.68(1.92%)
Day’s Range― - ―
52-Week RangeCHF21.20 - CHF34.80
Previous CloseN/A
Volume262.00
Average Volume (3M)3.74K
Market Cap
CHF157.49M
Enterprise ValueCHF81.92
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.31
Next Earnings
Sep 03, 2026EPS Estimate
-1.71Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding5,854,584
10 Day Avg. Volume2,578
30 Day Avg. Volume3,744
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-6.33
Revenue Forecast (FY)CHF5.48M
BioVersys AG News
BIOV FAQ
What was BioVersys AG’s price range in the past 12 months?
BioVersys AG lowest stock price was CHF21.20 and its highest was CHF34.80 in the past 12 months.
What is BioVersys AG’s market cap?
BioVersys AG’s market cap is CHF157.49M.
When is BioVersys AG’s upcoming earnings report date?
BioVersys AG’s upcoming earnings report date is Sep 03, 2026 which is in 46 days.
How were BioVersys AG’s earnings last quarter?
BioVersys AG released its earnings results on Apr 01, 2026. The company reported -CHF1.85 earnings per share for the quarter, missing the consensus estimate of -CHF1.07 by -CHF0.78.
Is BioVersys AG overvalued?
According to Wall Street analysts BioVersys AG’s price is currently Overvalued.
Does BioVersys AG pay dividends?
BioVersys AG does not currently pay dividends.
What is BioVersys AG’s EPS estimate?
BioVersys AG’s EPS estimate is -1.71.
How many shares outstanding does BioVersys AG have?
BioVersys AG has 5,854,584 shares outstanding.
What happened to BioVersys AG’s price movement after its last earnings report?
BioVersys AG reported an EPS of -CHF1.85 in its last earnings report, missing expectations of -CHF1.07. Following the earnings report the stock price went down -0.35%.
Which hedge fund is a major shareholder of BioVersys AG?
Currently, no hedge funds are holding shares in CH:BIOV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Molecular Partners AG
―
Basilea Pharmaceutica
―
Newron Pharmaceuticals SpA
―
Santhera Pharmaceuticals Holding
―
RELIEF THERAPEUTICS Holding
―